News Quantified

SNGX – soligenix, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice [Yahoo! Finance]

Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice

Soligenix Announces Recent Accomplishments And First Quarter 2024 Financial Results [Yahoo! Finance]

Soligenix Announces Recent Accomplishments And First Quarter 2024 Financial Results

Soligenix to Present at Upcoming Conferences [Yahoo! Finance]

Form DEFA14A SOLIGENIX, INC.

Form 424B3 SOLIGENIX, INC.

Form 10-Q SOLIGENIX, INC. For: Mar 31

Form ARS SOLIGENIX, INC. For: Dec 31

Form DEF 14A SOLIGENIX, INC. For: May 23

Top News Gainers

1/3 Form 8-K SOLIGENIX, INC. For: Jan 02 26.2%

3/19 Soligenix Announces Positive Top-line Results for its Pivotal Phase 3 FLASH Trial Evaluating SGX301 in Treatment of Cutaneous T-Cell Lymphoma 20.5%

5/14 Form 10-Q SOLIGENIX, INC. For: Mar 31 12.3%

7/26 Form DEF 14A SOLIGENIX, INC. For: Sep 06 12.3%

3/30 Form 10-K SOLIGENIX, INC. For: Dec 31 12.0%

12/13 Form 4 SOLIGENIX, INC. For: Dec 12 Filed by: Donini Oreola 10.9%

7/8 Soligenix Announces Appointment of Diane L. Parks to its Board of Directors 9.5%

10/3 Soligenix to Present at the 20th Annual GCFF Investor Conference in Vancouver, British Columbia, Canada 7.7%

7/10 Form 4 SOLIGENIX, INC. For: Jun 28 Filed by: Pearson Mark E. 7.6%

9/17 Form 8-K SOLIGENIX, INC. For: Sep 16 6.6%

Top News Decliners

3/23 Soligenix and University of Hawai?i at Manoa Initiate Work on Novel Coronavirus Vaccine for COVID-19 -30.0%

4/6 Soligenix Receives European Patent for Therapeutic Use of Synthetic Hypericin to Treat Cutaneous T-Cell Lymphoma -20.0%

4/16 Soligenix Announces Exclusive Licensing Agreement for Novel Vaccine Adjuvant from BTG Specialty Pharmaceuticals -15.8%

4/30 Soligenix Announces Positive Phase 3 FLASH Study Demonstrates Increased Efficacy with Continued Treatment in Patients with Cutaneous T-Cell Lymphoma -11.4%

8/29 Soligenix to Present at the RHK Capital 2019 Disruptive Growth Conference -10.1%

3/19 Solgenix up 16% premarket on positive SGX301 data [Seeking Alpha] -10.0%

12/7 Soligenix, Inc. (NASDAQ: SNGX) was downgraded by analysts at ValuEngine from a "sell" rating to a "strong sell" rating. -9.3%

4/20 Soligenix's Upcoming Catalyst For Pipeline Product SGX301 Could Offer A Nice Trade Opportunity [Seeking Alpha] -8.1%

8/13 Form 10-Q SOLIGENIX, INC. For: Jun 30 -8.0%

12/12 Soligenix initiates clinical trial of heat stable ricin toxin vaccine [Seeking Alpha] -7.5%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day